Evaluation of the potency of FDA-approved drugs on wild type and mutant SARS-CoV-2 helicase (Nsp13)

SARS-CoV-2 has caused COVID-19 outbreak with nearly 2 M infected people and over 100K death worldwide, until middle of April 2020. There is no confirmed drug for the treatment of COVID-19 yet. As the disease spread fast and threaten human life, repositioning of FDA approved drugs may provide fast op...

Descripción completa

Detalles Bibliográficos
Autores principales: Ugurel, Osman Mutluhan, Mutlu, Ozal, Sariyer, Emrah, Kocer, Sinem, Ugurel, Erennur, Inci, Tugba Gul, Ata, Oguz, Turgut-Balik, Dilek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7513821/
https://www.ncbi.nlm.nih.gov/pubmed/32980406
http://dx.doi.org/10.1016/j.ijbiomac.2020.09.138

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7513821/
https://www.ncbi.nlm.nih.gov/pubmed/32980406
http://dx.doi.org/10.1016/j.ijbiomac.2020.09.138

Ejemplares similares